Months after cancer drug trial, Merus agrees to be bought at 41% premium

1 month ago 39
Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.
Read Entire Article
  1. Homepage
  2. category-label-
  3. Months after cancer drug trial, Merus agrees to be bought at 41% premium

Related

Even if baby boomers don’t break Social Security, millennials and Gen Z will be in trouble. Here’s why.

Even if baby boomers don’t break Social Security, millennial...

19 minutes ago 1
Health-insurance premiums are soaring. How to tell if switching to a high-deductible plan during open enrollment is best for you.

Health-insurance premiums are soaring. How to tell if switch...

20 minutes ago 1
Hershey’s Halloween sales have disappointed, but there’s hope for last-minute buying

Hershey’s Halloween sales have disappointed, but there’s hop...

34 minutes ago 1

Trending

1. fmc stock
2. ben shelton
3. ticketmaster
4. nyc marathon
5. cava stock
6. comcast stock
7. tyler perry
8. animal crossing
9. indiana fever
10. navy federal

Popular

Stellar Edges Lower 0.4% to $0.3123 as Partnership News Surfaces

Stellar Edges Lower 0.4% to $0.3123 as Partnership News Surf...

6 days ago 56
Ledger and Trezor 2025 hardware wallets released: What’s new for users?

Ledger and Trezor 2025 hardware wallets released: What’s new...

6 days ago 50
Kyrgyzstan launches stablecoin on BNB Chain, confirms future CBDC rollout

Kyrgyzstan launches stablecoin on BNB Chain, confirms future...

4 days ago 49
President Trump pardons Binance founder CZ: Report

President Trump pardons Binance founder CZ: Report

6 days ago 43
AI Miners Surge Pre-Market on Record $38B Oracle Data Center Deal Boosts Sector

AI Miners Surge Pre-Market on Record $38B Oracle Data Center...

6 days ago 42
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Tayedi Search engine 2025. All rights are reserved